You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anlotinib

Showing 1 - 25 of 349
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Combined Hepatocellular Cholangiocarcinoma Trial (gemcitabine ,oxaliplatin,anlotinib,Sintilimab)

Not yet recruiting
  • Combined Hepatocellular Cholangiocarcinoma
  • gemcitabine ,oxaliplatin,anlotinib,Sintilimab
  • (no location specified)
Sep 10, 2023

Pheochromocytoma, Paraganglioma Trial in Beijing (Anlotinib HCl)

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • Anlotinib hydrochloride
  • Beijing, China
    Peking Union Medical College Hospital
May 22, 2023

Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride

Not yet recruiting
  • Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
  • Anlotinib Hydrochloride Capsule and Penpulimab
  • Beijing, Beijing, China
    YansongLin
Sep 25, 2023

Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

Not yet recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Therapy
  • (no location specified)
Aug 16, 2023

Sintilimab and Anlotinib in Combination With Chemo Trial in Xi'an (Sintilimab and anlotinib in combination with chemo)

Completed
  • Sintilimab and Anlotinib in Combination With Chemotherapy
  • Sintilimab and anlotinib in combination with chemotherapy
  • Xi'an, Shanxi, China
  • +1 more
Aug 27, 2023

Breast Cancer Trial in Xi'an (metronomic oral vinorelbine plus anlotinib)

Recruiting
  • Breast Cancer
  • metronomic oral vinorelbine plus anlotinib
  • Xi'an, Shaanxi, China
    Xi'an International Medical Center Hospital
Aug 27, 2023

Breast Cancer Trial (Disitamab Vedotin+Anlotinib)

Not yet recruiting
  • Breast Cancer
  • Disitamab Vedotin+Anlotinib
  • (no location specified)
Aug 14, 2023

To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced

Not yet recruiting
  • To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
  • Hydrochloride anlotinib
  • +2 more
  • (no location specified)
Mar 6, 2023

Aumolertinib, Anlotinib, TP53 Trial (Aumolertinib,Anlotinib)

Not yet recruiting
  • Aumolertinib
  • +4 more
  • (no location specified)
Mar 8, 2023

Adjuvant Treatment Trial (anlotinib+CAPEOX/SOX)

Not yet recruiting
  • Adjuvant Treatment
  • (no location specified)
Feb 15, 2023

Gastric Cancer Trial in Xi'an (Penpulimab combined with Anlotinib Hydrochloride Capsules and chemo;Cadonilimab combined with

Not yet recruiting
  • Gastric Cancer
  • Penpulimab combined with Anlotinib Hydrochloride Capsules and chemotherapy;Cadonilimab combined with Anlotinib Hydrochloride Capsules and chemotherapy
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of Air Force Military Medical Univ
Mar 23, 2023

Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Sep 18, 2023

Advanced NSCLC Trial in Jinan (almonertinib)

Recruiting
  • Advanced Non-small Cell Lung Cancer
  • Jinan, Shandong, China
    Degan Lu
Sep 12, 2023

Cervical Cancer Trial in Wuhan (Cadonilimab, Anlotinib)

Recruiting
  • Cervical Cancer
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Apr 5, 2023

Advanced Biliary Tract Cancer Trial (anlotinib+TQB2450+nab-paclitaxel+cisplatin)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • (no location specified)
Apr 2, 2023

Hepatocellular Carcinoma Trial in Shanghai (Anlotinib and TQB2450)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Anlotinib and TQB2450
  • Shanghai, Shanghai, China
    Zhongshan hospital
Sep 4, 2023

Nasopharyngeal Tumors Trial (The combination treatment of anlotinib, penpulimab and capecitabine.)

Not yet recruiting
  • Nasopharyngeal Neoplasms
  • The combination treatment of anlotinib, penpulimab and capecitabine.
  • (no location specified)
Apr 10, 2023

Locally Advanced or Metastatic Radioiodine-Refractory

Recruiting
  • Thyroid Neoplasms
  • Anlotinib Hydrochloride Capsule
  • Beijing, Beijing, China
  • +2 more
Aug 9, 2023

Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • Oral Topotecan Combined With Anlotinib
  • Shanghai, China
    Xinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023

Esophageal Squamous Cell Carcinoma Trial in Hangzhou (Cadonilimab combined Anlotinib)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Cadonilimab combined Anlotinib
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 6, 2023

Soft Tissue Sarcoma, High Risk of Recurrence, Anlotinib Trial in Shanghai (drug, radiation, procedure)

Recruiting
  • Soft Tissue Sarcoma
  • +3 more
  • Anlotinib
  • +2 more
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Nov 1, 2022

Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jun 6, 2023

Anlotinib Treatment Response Using Contrast Enhanced Ultrasound

Recruiting
  • Pheochromocytoma, Metastatic
  • +3 more
  • Contrast-enhanced ultrasound(CEUS)
  • Beijing, China
    Peking Union Medical College Hospital
Aug 28, 2023

Esophageal Cancer Trial in Weihui, Suining, Beijing (Utidelone and anlotinib)

Recruiting
  • Esophageal Cancer
  • Utidelone and anlotinib
  • Weihui, Henan, China
  • +2 more
May 10, 2023

NSCLC Trial (BR790+anlotinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Feb 8, 2023